Liège, Belgium

Hyloris Developments Sa


USPTO Granted Patents = 10

Forward Citations = 2

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal John Somberg (3 out of 4 patents)

silverMedal Atul Patil (3 out of 3 patents)

bronzeMedal Somberg John (2 out of 2 patents)

4.  Thomas Gerner Jacobsen (2 out of 2 patents)

5.  Paul Hafey (1 out of 4 patents)

6.  L Diane Bruce (1 out of 1 patent)

7.  Mohammad Alkhalili (1 out of 1 patent)

8.  Mary Beth G Erstad (1 out of 1 patent)

9.  Venkata Radha Krishna Bodagala (1 out of 1 patent)

10.  Shanmukha Srinivas Mule (1 out of 1 patent)

11.  Sravan Kumar Thondapu (1 out of 1 patent)

12.  Soumya Kondaveeti (1 out of 1 patent)

13.  Ajay Kumar Bachupally (1 out of 1 patent)


10 patents:

Company Overview
Hyloris Developments SA is a biopharmaceutical company based in Liège, Belgium, focused on developing innovative drug formulations and delivery systems. The organization specializes in enhancing the therapeutic profiles of existing medications, aiming to improve patient outcomes through advanced pharmaceutical technologies. Hyloris is dedicated to addressing unmet medical needs by leveraging its expertise in drug development and formulation science, contributing to the evolving landscape of healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#3 in Liège

#255 in Belgium

#55,986 in the World

Liège, BE
Liège, Belgium
Forward Citations = 2

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hyloris Developments Sa. Retrieved from https://idiyas.com/company/hyloris-developments-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…